← Back to patent-cliff list
HSK-42360
Tier C — Watch / tradeHSK-42360
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：B-raf
Indications (approved)：Colorectal cancer, 脑癌, Solid tumour
Regional status
US
-
EU
-
China
Phase II
2026-07-20
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of HSK-42360?
Approved indications include: Colorectal cancer, 脑癌, Solid tumour.
When does the HSK-42360 patent expire?
No public expiry year is available for HSK-42360 yet; this page updates once verified.
How do I get a quote for HSK-42360 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29